phase i/ii bruin study: pirtobrutinib in patients intolerant to a covalent btk inhibitor
Published 1 year ago • 113 plays • Length 1:08Download video MP4
Download video MP3
Similar videos
-
1:32
genomic evolution & resistance to pirtobrutinib in covalent btk inhibitor pre-treated cll
-
2:39
updates from the phase i/ii bruin study: pirtobrutinib in cll
-
2:25
results from a phase i/ii trial of pirtobrutinib and lv20.19 for patients with r/r lymphomas
-
1:52
phase i dose-escalation study of the bet inhibitor incb057643 in r/r myelofibrosis
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
2:58
results of a phase ib study of ibrutinib obinutuzumab in r/r cll
-
2:09:55
hematology tutorial for r2 internal medicine — part i
-
26:22
what has changed in itp over the last 20 years professor david kuter
-
9:50
what i wish i’d known about preparing for the frcpath part 2 - dr veronica moyo
-
2:56
bioteke malaysia- 4in1 multiple respiratory multipathogen antigen test kit (covid influenza a&b rsv)
-
1:32
shifting the treatment landscape of itp: novel agents and future outlooks
-
3:40
master class in transplantation and hematology: highlights
-
4:48
an insight into the management of cytopenias in mf
-
3:10
novel aml treament approaches
-
1:47
shared treatment decision-making
-
1:31:17
new perspectives for cancer treatment: the role of basic research. serie #riicerca